About Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
Headquarters251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Founded2018
StatusActive

Patents1 patent

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

Search all patents on Heelky →

Reviews

No reviews yet. Worked with Assertio Therapeutics, Inc.? Be the first to share your experience.

Write a review →

Location

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

Is this your company?

Claim this page for free to add your logo, products, photos and jobs, and to answer reviews.

Claim this page

Share this company

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

Copy link

Share on

QR code

Scan it with a phone camera to open this page, or download it for a flyer, a slide or a badge.

Join Heelky to connect, hire and grow

Create a free account to message people, apply to jobs and post missions.

Join now — it's free

Choose your language

Heelky will remember your choice.

Other languages

Available languages: 70 About languages on Heelky